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Size  exclusion  chromatography  is a standard  method  in  quality  control  of  biopharmaceutical  proteins.
In contrast,  vaccine  analysis  is  often  based  on activity  assays.  The  hemagglutination  assay  is  a  widely
accepted  inﬂuenza  quantiﬁcation  method,  providing  no insight  in  the size  distribution  of  virus  par-
ticles.  Capabilities  of  size  exclusion  chromatography  to complement  the  hemagglutination  assay  are
investigated.  The  presented  method  is  comparatively  robust  regarding  different  buffer  systems,  ionic
strength  and  additive  concentrations.  Addition  of  200  mM  arginine  or sodium  chloride  is necessary  to
obtain  complete  virus  particle  recovery.  0.5  and  1.0  M arginine  increase  the hydrodynamic  radius  of  the
whole  virus  particles  by  5 nm.  Sodium  citrate  induces  virus  particle  aggregation.  Results  are  conﬁrmed  by
dynamic  light  scattering.  Retention  of a H1N1v  strain correlates  with  DNA  contents  between  5 ng/mL  and
670  ng/mL.  Quantitative  elution  of  the  virus  preparations  is  veriﬁed  on  basis  of  hemagglutination  activ-
ity.  Elution  of  hemagglutination  inducing  compounds  starts  at a ﬂow  channel  diameter  of 7000  nm.  Therocess analytical techniques universal  applicability  is demonstrated  with  three  different  inﬂuenza  virus  samples,  including  an  indus-
trially  produced,  pandemic  vaccine  strain.  Size  distribution  of  the pandemic  H1N1v  5258, H1N1  PR/8/34,
and  H3N2  Aichi/2/68  preparations  spreads  across  inter-  and  intra-particle  volume  and  extends  to  the
secondary  interaction  dominated  range.  Thus,  virus particle  debris  seems  to induce  hemagglutination.
Fragments  generated  by  0.5% TritonTM X-100  treatment  increase  overall  hemagglutination  activity.
©  2016  The  Author(s).  Published  by Elsevier  B.V.  This  is an  open  access  article  under  the CC. Introduction
Vaccination is an effective cure against the pandemic outbreak
f inﬂuenza. Various inﬂuenza vaccines from different manufactur-
rs are based on inactivated whole virus particles. Inﬂuenza virus
articles have a size of 80–120 nm.  Hemagglutinin (HA) and neu-
aminidase are the two most abundant proteins on the surface of
nﬂuenza A virus particles. Currently, 17 different HA and 10 differ-
nt neuraminidases have been characterized and give name to the
ifferent inﬂuenza A subtypes [1]. The amount of HA in an inﬂuenza
accine is a crucial parameter for release of the biopharmaceutical.
uidelines by the European Pharmacopoeia require 15 g of HA
ntigen for each of the present virus strains in a trivalent human
accine [2].
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Currently, HA quantiﬁcation mostly relies on two methods: the
single radial immunodiffusion (SRID) assay and the HA assay. SRID
is based on antigen binding and is the gold standard for release
of human vaccines [3]. The HA assay utilizes hemagglutination
of erythrocytes [4]. Dilutions of the investigated virus sample are
incubated with a chicken erythrocyte preparation. In case sufﬁcient
virus particles are present to induce hemagglutination, erythro-
cytes will ﬂoat carpet-like in solution. Virus particle concentrations
are estimated assuming hemagglutination requires one virus par-
ticle per erythrocyte. This assay dates back to the 1940s and is
currently still accepted in research, development, quality con-
trol testing and the release of animal vaccines. Drawbacks of this
method are the lack of standardization, its discrete format, devi-
ations due to erythrocyte aging [5], secondary interactions of pH,
buffer ions [6] and other compounds in complex virus samples.
Virus inactivation agents have been shown to speciﬁcally affect HA
activity of different strains [7,8]. Jonges et al. evaluated the use of
different conditions and agents for viral inactivation. Heat and -
propiolactone lead to a decreased HA-titer. Comparatively smaller
losses of the HA-titer can be observed after formalin treatment.
e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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ritonTM X-100 concentrations exceeding 0.2% lead to a complete
oss of hemagglutination activity of H3N2. However, the deter-
ined HA-titer of H7N3 exceeds the initial value after treatment
ith 1% TritonTM X-100 [8]. The inﬂuence on HA activity extends
o inorganic ions typically used during downstream processing.
alcium ions have been shown to mediate hemagglutination in
resence of amyloid proteins [9].
Both methods, SRID and HA assay, are generally recognized
nd are being applied in research and development of puriﬁca-
ion processes. Kalbfuss et al. use the HA assay for mass-balancing
f ﬁltration. They conclude that roughly 40% of the HA activity is
eposited on or inside the membrane, since it could neither be
ecovered in the permeate fraction nor in the retentate. They fur-
her suggest that this may  represent cell debris [10]. Changes in
A activity due to fragmentation of initially spherical virus parti-
les and aggregation might contribute as well. A recently published
anuscript of our group describes discrepant mass balances, as
ell. Occasionally, the HA activity recovered from different anion
xchange resins exceeds HA activity prior to chromatography by
ore than 100% [11]. In this case, non-conformity of activity was
hown to be independent from the sample matrix. Thus, compar-
ng the efﬁciency of different puriﬁcation schemes based on HA
ctivity may  lead to an incomplete picture. This is in particular
mportant when comparing data obtained with different virus feed-
treams. Non-closing mass balances and reproducibility issues are
ddressed by another manuscript by Kalbfuss et al., where they
uggest the use of a continuous HA assay format [12]. Undoubt-
dly, this assay format leads to a general improvement of the assay.
owever, matrix interference remains a problem. Consequently,
uffer exchange steps might be necessary to quantify samples from
rocess development.
During the last years, enhanced process understanding and
ontrol has been pushed by the authorities [13]. This can be accom-
lished through process analytical technologies that are applicable
o a wide design space of conditions potentially being used during
he manufacturing process. Public institutions, such as the Euro-
ean Medicine Agency (EMA), encourage research in the ﬁeld to
omplement the SRID assay [14]. Investigation of size, content, and
mmunogenicity of aggregates in the drug product or substance is
ecommended [14]. Numerous other techniques to either quantify
nﬂuenza virus particles or the activity have been published. These
nclude, but are not limited to: electron microscopy [15,16], surface
lasmon resonance [17,18], enzyme linked immunosorbent assay
ELISA) [19], and reversed phase high pressure liquid chromatog-
aphy [3]. Electron microcopy and surface plasmon resonance are
omparatively expensive. Surface plasmon resonance further suf-
ers from the same constraint as the SRID, since it requires an
ppropriate set of antibodies for new inﬂuenza strains. This holds
rue for most ELISAs. Reversed phase liquid chromatography is
ample destructive and strong interference with -propiolactone
5] limits its versatility. Except for electron microscopy, none of
he previously listed methods allows to investigate the aggregate
r fragment content of virus preparations. Alternative techniques
o investigate the size distribution of virus samples are dynamic
ight scattering (DLS) or differential centrifugal sedimentation [20].
LS is a mild, non-matrix assisted method, which is a great advan-
age with regards to potential secondary interactions. However,
t does not allow sampling of different size fractions of the virus
reparations for further activity analysis. In contrast, differential
entrifugal sedimentation is afﬂicted with shear forces.
Analytical size exclusion chromatography (SEC) is a non-
estructive technique that has been used for decades to analyze
he aggregate and fragment content of therapeutic proteins [21].
ecently, several approaches to apply SEC to the aggregate anal-
sis of virus and virus like particle samples have been published 1465 (2016) 117–125
[22–25]. Earlier approaches in SEC of viruses did not pay much
attention to this aspect [26]. Availability of SEC columns that
allow for size distribution analysis of large virus particles, such as
inﬂuenza, is limited. Due to the size of whole inﬂuenza virus parti-
cles, the estimated pore diameter distribution of such media should
range between 300 nm to 1000 nm.  Kalashnikova et al. found that
behavior of protein coated nanoparticles in adsorption chromatog-
raphy is mostly determined by the surface proteins [27]. This
may  hold true for non-adsorptive chromatography, as well. Hence,
assessing pore volume and pore diameter by inverse SEC of such
media is difﬁcult, due to the limited availability of monodisperse
proteins or protein-coated standards that have an appropriate
hydrodynamic radius. An alternative method is provided by mer-
cury porosimetry. Mercury intrudes at increasing pressure into the
intra-particle and inter-particle space of dry porous particles. Pore
diameters and pore volumes can be calculated from the required
pressure and the corresponding mercury volume [28].
Herein, we  present a complimentary analytical SEC method. The
current study includes 3 different inﬂuenza A virus strains. The
pandemic H1N1 vaccine strain 5258 is industrially produced in
mammalian cells. Inﬂuenza A H1N1 PR/8/34 and H3N2 Aichi/2/68
originate from embryonated chicken cells.
2. Material and methods
2.1. Inﬂuenza samples
The pandemic H1N1 vaccine strain (5258) was produced in
adherent Madin Darby Bovine Kidney (MDBK) cells at IDT Biologika
GmbH (Dessau-Roßlau, Germany). A reference process has been
published by Hundt et al. [29]. The H1N1v 5258 virus sample
was inactivated by -propiolactone treatment. The feedstream was
volumetrically concentrated by a factor of 20 to a HA activity of
2000 HAU/100 L. Samples for virus particle fragmentation exper-
iments were pre-puriﬁed by preparative SEC. TOYOPEARL HW-65F
(Tosoh Bioscience GmbH, Griesheim, Germany) was packed to a
bed height of 22 cm.  100 mM  sodium phosphate, pH 7.0 containing
200 mM sodium chloride was  used as mobile phase at a ﬂow rate of
150 cm/h. All chemicals were purchased from Sigma Aldrich/Merck
KGaA (Darmstadt, Germany), unless otherwise stated. Besides this
feedstream and SEC pre-puriﬁed feedstream, 15 H1N1v samples
with different host cell DNA contents were available. These sam-
ples originate from method development experiments. HA-activity
of these samples ranges from 6 HAU/100 L to 280 HAU/100 L.
Inﬂuenza A H1N1 PR/8/34 and H3N2 Aichi/2/68 were purchased
from Charles River Avian Vaccine Services (North Franklin, USA).
Both viruses were produced in embryonated chicken eggs and inac-
tivated by formalin treatment. The virus samples were puriﬁed and
concentrated to 2 mg/mL  by density gradient centrifugation.
2.2. Mercury porosimetry
Mercury porosity of the TSKgel G6000PWxl stationary phase
was accomplished with a PoreMaster 60-GT (Quantachrome,
Odelzhausen, Germany). Porosimetry experiments were conducted
according to the instructions of the instrument supplier. The resin
was washed with deionized water and freeze-dried at −45 ◦C and
0.03 mbar for 24 h with a Zirbus VaCo 2 (Bad Grund, Germany)
lyophilizer prior to the porosimetry experiments. 14.34 mL  wet
resin correspond to 1 column volume of TSKgel G6000PWxl
(7.8 mm ID × 30 cm L). Mass and volume of the freeze-dried resin
were determined and used for further calculation. 250 mg  of the
resin was ﬁlled into a penetrometer and connected to the mercury
porosimetry instrument. The penetrometer was ﬁlled with mer-
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ury at atmospheric pressure to ensure settling of the resin in the
enetrometer.
Mercury porosimetry data obtained with freeze-dried poly-
ethacrylate resins of lower pore diameter are in well agreement
ith iSEC data of these resins. Due to the lack of appropriate stan-
ards, such a comparison is not available for TSKgel G6000PWxl.
ore diameters were calculated using Eq. (1), where P  is the
hange in the applied pressure, Hg the surface tension of mercury,
 the contact angle between mercury and the surface and rpore the
ore radius [28].
P  = 2Hg·cos
rpore
(1)
.3. Dynamic light scattering experiments
The hydrodynamic radius of H1N1v in different buffers was
easured using a Beckmann Coulter DelsaMax Pro (Krefeld,
ermany) dynamic light scattering device. Dialysis into different
uffers was accomplished overnight at 4 ◦C. The investigated
uffer systems correspond to the buffers applied in analytical
ize exclusion chromatography: 100 mM sodium phosphate,
00 mM potassium phosphate, 100 mM sodium citrate, 100 mM 2-
bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol
Bis/Tris), 100 mM 2-(N-morpholino)ethanesulfonic acid (MES)
nd 100 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic
cid (HEPES), pH 7.0, all substituted with 200 mM sodium chloride.
nother set of buffers was based on 100 mM sodium phosphate,
H 7.0 with 0 mM,  200 mM,  500 mM and 1 M sodium chloride
r arginine/HCl, respectively. Each measurement consisted of 30
ndividual measurements with three repeats. Blanks of all buffers
ere included. Interlaced injections with 100% HPLC grade ethanol
ere used as negative control.
.4. Analytical size exclusion chromatography
TSKgel G6000PWxl (7.8 mm ID × 30 cm L) columns were used
or analytical SEC (Tosoh Bioscience GmbH). Low densities of resid-
al anionic groups on the surface of the 13 m polymethacrylate
eads prevent from ionic interactions with anions. The estimated
xclusion limit of this column for proteins is <20000 kDa.
Void volumes of TSKgel G6000PWxl and the different chro-
atography systems were determined with injections of 20 L
% acetone in water or 100 L of a 1 M sodium chloride solu-
ion. Acetone or salt were eluted in 100 mM sodium phosphate, pH
.0 + 200 mM sodium chloride at 1.0 mL/min. Retention of the cor-
esponding peaks was used as a reference in further calculations of
he intra- and inter-particle volumes and account for the respective
ystem void volumes, as well.
The applied ﬂow rate during SEC was 1.0 mL/min. Flow rates
ere chosen according to ﬁndings reported in a previous publi-
ation of our group [30]. 100 mM sodium phosphate, pH 7.0 with
00 mM sodium chloride was used as a standard SEC buffer. The
mpact of different buffer systems on virus particle recovery and
ize distribution was investigated with various buffers at pH 7.0:
00 mM potassium phosphate, 100 mM sodium citrate, 100 mM
EPES, 100 mM Bis/Tris and 100 mM MES. 200 mM sodium chlo-
ide was added to each of these buffers in order to suppress ionic
nteractions with the stationary phase and to stabilize the virus par-
icles. The effect of different concentrations of arginine and sodium
hloride was evaluated using 100 mM sodium phosphate buffer at
H 7.0. Sodium chloride and arginine hydrochloride were added
n concentrations of 0 mM,  200 mM,  500 mM and 1 M. Recoveries
ere determined by the area under the virus particle curves.
UV signals were traced at 214 nm/215 nm or 280 nm.  Buffer test-
ng was based on the UV 280 nm signal, since some of the applied 1465 (2016) 117–125 119
buffers absorb UV light at 214 nm/215 nm.  Due to the higher sig-
nal to noise ratio in 100 mM sodium phosphate buffer, other SEC
experiments were monitored at these lower wavelengths. 100 L
of the samples were injected in analytical experiments. The col-
umn  was  overloaded in semi-preparative SEC experiments. 1 mL  of
the virus samples was injected. The pre-puriﬁed and concentrated
H1N1 PR/8/32 and H3N2 Aichi/2/68 samples were 3-fold diluted
prior to injection. 1 mL  fractions were collected. All samples were
analyzed in duplets or triplets.
2.5. Hemagglutination assay
The hemagglutination activity was  determined using a Tecan
Freedom Evo 150. Chicken erythrocyte preparations in Alsever
solution were purchased from preclinics (Potsdam, Germany).
4 mL  of the erythrocyte preparation were diluted with 40 mL
phosphate buffered saline (PBS) consisting of 1.54 mM potassium
dihydrogen phosphate, 8.10 mM disodium hydrogen phosphate,
2.68 mM potassium chloride and 137 mM sodium chloride, pH 7.5
at 25 ◦C. After centrifugation at 500g, pelleted erythrocytes were
resuspended in 40 mL  cold PBS. Erythrocyte concentration was
determined with a Fuchs-Rosenthal cytometer and adjusted to
2 × 107 cells per mL.  100 L of the H1N1 containing samples were
transferred into every second row of the ﬁrst column of U-bottom
96 well plates. A 1:20.5 dilution of the samples was  pipetted into
the ﬁrst well of the remaining rows. Serial 1:2 dilutions of all sam-
ples in phosphate buffered saline were completed. 100 L of the
erythrocyte solution were added to all wells and plates were incu-
bated for one hour at room temperature. Results were evaluated
manually and by absorbance readings at 700 nm.
2.6. Virus particle fragmentation
Fragmentation of pre-puriﬁed H1N1v 5258 was accomplished
through treatment with TritonTM X-100 or heat incubation accord-
ing to the protocol from Jonges et al. [8]. 1 mL aliquots of the
pre-puriﬁed virus sample were incubated for 1 h with 0.0, 0.2, 0.5,
and 1.0% (v/v) TritonTM X-100 at room temperature. Samples were
dialyzed into 100 mM sodium phosphate buffer, pH 7.0 containing
200 mM sodium chloride at 4 ◦C to remove the detergent. Alterna-
tively, 1 mL  samples were incubated for 30 min  at 20, 40, 50, 60,
and 70 ◦C. Experiments were performed at least in duplets.
2.7. DNA assay
Double stranded DNA contents of the 15 samples from method
development experiments were determined using a Qubit dsDNA
HS assay kit (Thermo Fisher Scientiﬁc, Dreieich, Germany). The
assay was conducted according to the instructions of the manu-
facturer. In brief, 20 L of the samples were mixed with 180 L
of the assay buffer. The double stranded DNA concentration was
determined through ﬂuorescence measurements. The lower limit
of detection was 5 ng/mL.
3. Results and discussion
3.1. Pore diameter measurements
14.34 mL  packed wet bed correspond to 3.1 g freeze-dried resin
with a non-compressed volume of 17.5 mL. This corresponds to a
methacrylate mass density of 0.22 g/mL in the wet packed bed.
Comparing volumes of the wet  packed bed and the freeze-dried
free resin leads to a compression factor of roughly 1.2. This is in
agreement with data obtained for polymethacrylate resins [31,32],
indicating that the applied freeze-drying procedure mostly pre-
serves the spherical shape of the resin particles. The calculated
120 J. Vajda et al. / J. Chromatogr. A 1465 (2016) 117–125
Fig. 1. Mercury porosimetry data for the TSKgel G6000PWxl resin. The mean pore
diameter of the resin is 250 nm.  The pore diameter distribution ranges from 20 nm
to  2000 nm.  Intra-particle volume merges into inter-particle volume.
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Fig. 2. Hydrodynamic radiuses of H1N1v samples in different buffer systems. Hydro-
dynamic radiuses are in the range of 50 nm. Arginine addition or use of citrate buffer
hardly access the intra-particle volume. It seems separation of virusolume contribution of methacrylate to the packed column bed is
.6 mL.
The pore diameter distribution of TSKgel G6000PWxl was  deter-
ined using mercury porosimetry. Intra- and inter-particle volume
annot be delimited. The intruded mercury volume is continuously
rowing and strives through a minimum at 2000 nm (Fig. 1). Given
000 nm deﬁnes the border between intra- and inter-particle vol-
mes, corresponding values can be calculated. The resulting pore
iameter distribution ranges from 20 nm to 2000 nm with a mean
alue of 250 nm.  The calculated intra-particle volume of the column
s 3.9 mL.  These results suggest that virus particles are not excluded
rom the pore volume of the column. Available volume of pores or
ow channels with a diameter ranging from 500 nm to 3000 nm is
imited, however. At the low end of calibration, capacity for host
ell proteins and other low molecular impurities is limited, as well.
Virus particle aggregates represent a product related impu-
ity with comparatively greater hydrodynamic radius. Capacity for
ggregates that can be separated due to pore diffusion correlates
nversely with their hydrodynamic radius. However, separation
f very large virus aggregates might eventually be supported by
ydrodynamic effects and perfusive ﬂow channels [33]. The calcu-
ated inter-particle volume of the column is 5.6 mL  and directly
erges with the intra-particle volume. The greatest part of the
nter-particle volume constitutes of ﬂow channels with diameters
maller than 10,000 nm.  Such ﬂow channels contribute with 4.0 mL
o the total volume of the packed bed. Due to the size distribu-
ion of the polymethacrylate particles, column packings exhibit a
ize distribution with regards to the ﬂow channel diameters. Flow-
hrough channels in the particles may  contribute to this volume, as
ell. Both may  further extend the separation range. Linearity of this
xtension remains to be proven, since the availability of appropriate
alibration standards is limited.
The presented pore diameter data indicates that aggregates,
onomers and fragments of inﬂuenza whole virus particles can
e separated, analytically. Hence, the column is used for the sub-
equent analytical and semi-preparative SEC experiments. In the
emi-preparative approach, loadings did not exceed 0.7 mg.  This
orresponds to a loaded mass of <0.05 mg/mL  of packed bed.
reparative separations require high capacity for host cell protein,
hile a group separation of virus particles might be satisfying. Tohis end, resins with greater pore volume provided by smaller pores
ight be more efﬁcient.lead to an increase of the hydrodynamic radius. In absence of sodium chloride or
arginine, measured radiuses are comparatively smaller.
3.2. Dynamic light scattering
Hydrodynamic radiuses of H1N1 samples in the different buffer
systems are shown in Fig. 2. Hydrodynamic radiuses are in the
range of 50 nm.  This is in accordance with values reported in lit-
erature [34]. 100 mM sodium phosphate buffer +200 mM sodium
chloride lead to a hydrodynamic radius of 59 nm.  If this is set as
a reference, sodium citrate buffer and sodium phosphate buffer
substituted with 0.5 or 1.0 M arginine lead to an increase of the
hydrodynamic radius. Arginine is well-known for its ability to inter-
act with proteins in solution [35,36,21]. The introduced changes in
the electric double layer seem to increase the hydrodynamic radius
of the virus particles.
The increase of the average hydrodynamic radius in citrate
might be due to hydrophobic interactions, since sodium citrate is a
kosmotropic buffer. Impurities in the feedstream, such as DNA, host
cell proteins or cell debris might interact hydrophobically with the
whole virus particles. Aggregation based on hydrophobic interac-
tions might contribute, as well. Resolution of different size species
in DLS data can be difﬁcult. In many cases an average hydrodynamic
radius is provided.
The smallest hydrodynamic radius was  obtained in 100 mM
sodium phosphate buffer without sodium chloride or arginine.
The hydrodynamic radius in this buffer is 27 nm.  The lower ionic
strength of this solution probably affects the electric double layer
of the virus particles.
3.3. Size exclusion chromatography in different buffers
Six different buffer systems at a concentration of 100 mM and pH
7.0 were applied for SEC of H1N1v. Furthermore, different concen-
trations of arginine and sodium chloride were added as additives
to 100 mM sodium phosphate. Corresponding chromatograms are
shown in Fig. 3A and B. Retention of the whole virus particle peak
remains constant at 8.4 min. Provided 2000 nm is the threshold
between intra- and inter-particle volume, whole virus particlesparticles is mostly based on perfusive ﬂow channels with a diame-
ter of 3500 nm.
J. Vajda et al. / J. Chromatogr. A
Fig. 3. SEC chromatograms of H1N1v. A: Separations in 100 mM sodium phosphate,
100 mM sodium citrate, 100 mM HEPES, 100 mM MES, 100 mM Bis/Tris and 100 mM
potassium phosphate, all pH 7.0. All buffers were substituted with 200 mM sodium
chloride to supress ionic secondary interactions. Virus particles elute at 8.4 min  in all
buffer systems. Citrate buffer leads to elution of a small peak prior to the whole virus
particle peak. B: Separations in 100 mM sodium phosphate buffer containing 0 mM,
200 mM,  500 mM or 1 M sodium chloride or arginine/HCl, respectively. Increasing
concentrations lead to an increase of the area under the peak of the components
eluting at 10 min  or later. The area under the curve of the whole virus particle peak
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mediating molecules increases. This has important implications onecreases in absence of additive.
The applied buffer systems and additives hardly affect the elu-
ion volume of virus particles. 100 mM sodium phosphate with an
ddition of 1 M arginine represents an exception. In this buffer sys-
em, retention is shifted by 0.1 min. DLS measurements in presence
f arginine reveal an increase in the hydrodynamic radius by 5 nm
ompared to 100 mM sodium phosphate +200 mM sodium chloride
Fig. 2). This increase may  account for the increased retention due
o the addition of 1 M arginine.
Addition of arginine further affects peak shape and height of
he substances eluting at 10 min  and later. The peaks decrease and
ecome broader at increasing arginine concentrations. The feed-
tream samples are a complex mixture of virus particles and cell
ebris. The previously discussed arginine-protein interactions are
lso known to suppress secondary interactions in SEC [35,36,21].
his may  explain why the least eluting impurity elutes compara-
ively earlier. This impurity cannot be eluted within the separation
ange of the column in buffer systems without arginine. Addition of
odium chloride even increases retention further. Hence, this least
eak most probably represents a hydrophobic impurity, such as 1465 (2016) 117–125 121
the M2 membrane channel protein. Changes in peak shape due to
addition of arginine might be based on these effects, as well.
Sodium citrate buffer represents another exception, which is in
agreement to DLS data. A small and broad peak elutes prior to the
whole virus particle peak. This peak might constitute virus particle
aggregates. Aggregation is one factor affecting size distribution of
virus particle preparations. Sodium citrate is a kosmotropic buffer.
The support of hydrophobic interactions may  lead to virus particle
aggregation. DLS data indicates an increase in the average hydrody-
namic radius (Fig. 2). Aggregates as a separate scattering compound
cannot be identiﬁed. However, DLS of size distributions such as
the virus particle samples may  not clearly distinguish between the
different species.
Chromatograms of SEC indicate that a certain ionic strength
similar to physiological conditions supports recovery of whole
virus particles. The virus particle peak in 100 mM sodium phos-
phate buffer without additive is comparatively smaller. The areas
under the curve of the whole virus particle peaks in all buffers are
shown in Fig. 4A and B. 100 mM sodium phosphate without additive
lead to an area of 21 mAU*min, whereas a maximum recovery of
34 mAU*min can be achieved in 100 mM sodium phosphate buffer
with addition of 200 mM sodium chloride. Further increase of the
sodium chloride addition decreases the whole virus particle recov-
ery. This might be due to hydrophobic interactions. According to
these results, there is an optimum ionic strength. Ionic secondary
interactions must be suppressed on the one hand. On the other,
hydrophobic secondary interactions must not be supported and
residual anionic charges on the resin surface must not be saturated
with counter ions.
Whole virus particle recovery in sodium citrate buffer is sim-
ilar to sodium phosphate buffer. Given the peak eluting prior to
the whole virus particle peak in citrate buffer represents virus par-
ticle aggregates, hydrophobic interactions between virus particles
appear more likely than between virus particles and the stationary
phase. The low density residual anionic charges on the surface of
the stationary phase may  be hold responsible for this difference.
3.4. Hemagglutinin activity of size exclusion chromatography
fractions
Semi-preparative SEC chromatograms of H1N1v 5258, H1N1
PR/8/34, and H3N2 Aichi/2/68 on TSKgel G6000PWxl are shown
in Fig. 5. The HA activity of the collected fractions is plotted on
the right y-axis. The higher system dead volume of the prepara-
tive system and the great injection volume have a negative impact
on chromatographic performance. Fractions corresponding to the
peak eluting between 8 and 10 min  have the highest HA activity.
Fractions eluting after the main virus peak contain HA activity, as
well. Elution of HA activity ranges from 6.5 mL  to 19.5 mL.  This cor-
responds to pore and channel diameters starting at 7000 nm and
smaller. The lower pore diameter cannot be determined, since elu-
tion of HA activity extends to the range dominated by secondary
interactions.
Roughly 30% of the total HA activity elutes in the intra-particle
volume, representing lower molecular weight components.
Hemagglutination is considered a cross-linking reaction. It appears
reasonable that the hemagglutination inducing molecules must
not have a minimum size, but at least two functional sites. Thus,
virus particle debris most likely mediates hemagglutination. This
means virus particle fragmentation can lead to higher HA activity,
compared to whole virus particles, since the total number of HAthe use of HA activity as a measure for virus particle quantiﬁcation.
Virus particle quantiﬁcation based on activity measurements can
lead to signiﬁcantly overestimated virus particle contents. Differ-
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Fig. 4. Recovery determined by the area under the curve of the whole virus particle
peak of H1N1v from SEC. A: Recovery in 100 mM sodium phosphate and 100 mM
sodium citrate are higher compared to 100 mM HEPES, 100 mM MES, 100 mM
Bis/Tris and 100 mM potassium phosphate. B: 100 mM sodium phosophate was sub-
stituted with different concentrations of sodium chloride or arginine/HCl. Highest
recovery is obtained in presence of 200 mM sodium chloride. The applied arginine
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Fig. 5. Semi-prep SEC chromatograms of H1N1v 5258 (A), H1N1 PR/8/34 (B), H3N2
Aichi/2/68 (C) on TSKgel G6000PWxl. The HA activity of the corresponding SEC frac-oncentration has no impact on the area under the curve of the whole virus particle
eak.
nt degrees of virus fragmentation may  also contribute to the high
tandard deviation of the HA assay.
Summed HA activities of all fractions are in good agreement
ith the initial HA activity of the sample prior to SEC. 3.9 log of
he H1N1v 5852 sample were loaded in Fig. 5A. The HA activity of
ll fractions normalized against the volume is 4.1 log HAU. The ini-
ially injected HA activity of H1N1 PR/8/34 is 5.4 log HAU (Fig. 5B).
he recovered HA activity of this sample sums up to 5.2 log HAU. A
omparatively greater, but still acceptable loss appears for the frac-
ions of H3N2 Aichi/2/68 (Fig. 5C). 4.8 log HAU of the loaded 5.4 log
AU can be recovered from TSKgel G6000PWxl. Considering SEC
s a diluting method, HA activity of the fractions framing the virus
article peaks might be lower than the limit of detection of the HAtions is plotted in the graph. HA activity elutes in the inter- and intra-particle volume
and  extends to the volume dominated by secondary interactions. Roughly 30% of the
HA activity elutes in the intra-particle volume after the whole virus particle peak.
assay. Further, the HA assay uses a discrete format. Precision of the
assay could be enhanced by a greater number of erythrocyte dilu-
tions. Thus, the applied buffer conditions can be considered suitable
to quantitatively recover inﬂuenza virus samples.
3.5. Hemagglutination of different virus particle fragmentsThe previously reported results suggest that virus fragments
increase the total HA activity of a sample. Different virus inacti-
vation methods lead to decreasing or increasing HA activity. Jonges
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Fig. 6. Hemagglutination activity of SEC pre-puriﬁed H1N1v 5258 in HAU per 100 L
after heat incubation (A) and TritonTM X-100 treatment (B). HA activity of the Triton
reference sample is comparatively lower, due to an additional dialysis step. Tem-
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Fig. 7. SEC chromatograms of H1N1v 5258 after heat incubation (A) or TritonTM
X-100 treatment (B) on TSKgel G6000PWxl. Temperatures and detergent concen-
trations are indicated in the graph. The whole virus particle peak eluting at 8.4 min
decreases with increasing temperature or detergent concentration. Fragment peaks
increase. Except for the sample treated with 1% Triton, all components elute withineratures and Triton concentrations are indicated in the corresponding graphs. HA
ctivity decreases with increasing incubation temperature. 0.2% and 0.5% (v/v) Triton
ead to an increase in HA activity. Treatment with 1% Triton decreases HA activity.
t al. evaluated the impact of different inactivation agents on
emagglutination activity [8]. The experiments revealed that HA
ctivity of some inﬂuenza strains increases after treatment with
he membrane solubilizing detergent TritonTM X-100. In contrast,
hey found a decrease in HA activity in response to heat treatment.
A activity of H1N1v 5258 after heat incubation or TritonTM X-100
reatment is shown in Fig. 6A & B. Incubation at 50 ◦C or higher
eads to a loss of HA activity. In contrast, HA activity is increas-
ng after treatment with 0.2 and 0.5% TritonTM X-100, but declines
gain after treatment with 1% TritonTM X-100. Jonges et al. found
o such decrease after passing a maximum HA activity. However,
he general trend observed with H1N1v 5258 corresponds to their
tudy.
Analytical SEC chromatograms of the pre-puriﬁed and treated
amples are shown in Fig. 7A & B. All samples are pre-puriﬁed and
lute within the inter- and intra-particle volume, except for the 1%
riton treated sample. This sample contains compounds eluting in
he volume affected by secondary interactions. Increasing concen-
rations of the membrane solubilizing detergent generally increase
he fragment peaks. Detergents improve stability of vaccine formu-
ations [37,34]. Considering vaccines are often quantiﬁed through
A activity measurements, this stabilizing effect might be due to an
ncrease of the number of hemagglutination-inducing molecules.the inter- and intra-particle volume.
Aging of HA proteins might be compensated by membrane solubi-
lization.
Increasing the incubation temperature leads to an increase of
the low molecular weight peak, as well. It appears fragments do
not necessarily increase the HA activity of a sample. Activity of the
HA protein seems unaffected by low concentrations of TritonTM
X-100. The enveloping virus membrane is presumably affected,
though. Higher concentrations of the detergent may  lead to pro-
tein unfolding and subsequent activity loss. Unfolded proteins are
prone to secondary interactions and may  represent the peak eluting
after the intra-particle volume. Critical Triton concentrations may
depend on a particular HA. Inactivation by heat treatment seems
to immediately affect functionality of HA.
The presented data indicates that HA activity and size distribu-
tion of the investigated virus particle preparations do not correlate.
Eventually, this means size distribution analysis by SEC or other
techniques cannot substitute activity based assays of vaccine for-
mulations. However, the size of an antigen is an important trigger
for the immune system [38]. Thus, assessment of the size distri-
bution of vaccine preparations as an additional quality parameter
seems reasonable.
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Fig. 8. Retention of the whole virus particle peak of 15 H1N1v samples is plotted
against their corresponding DNA content. DNA concentrations range from <5 ng/mL
to  676 ng/mL. Data is widely scattered. Nevertheless, linear regression indicates an
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[19] S. Chun, C. Li, G. Van Domselaar, J. Wang, A. Farnsworth, X. Cui, et al.,
Universal antibodies and their applications to the quantitative determinationncrease of retention at increasing DNA purity.
.6. DNA purity
Changes in size distribution of whole virus particle prepara-
ions are not limited to aggregation or fragmentation. Adsorption
f host cell derived DNA might increase the average virus parti-
le size. Virus particle preparations with different host cell DNA
ontent were analyzed with SEC in 100 mM sodium phosphate, pH
.0 + 200 mM sodium chloride. Retention increases towards lower
olecular weight for virus samples with higher DNA purity. Cor-
esponding data is shown in Fig. 8. Retention of the whole virus
article peak is plotted against the DNA content determined by
 ﬂuorescence assay. Accuracy of such a calibrated SEC for quan-
iﬁcation of DNA purity is certainly lower compared to alternative
echniques. This method cannot replace polymerase chain reaction
r ﬂuorescence assays for quantiﬁcation of DNA in virus particle
amples. Nevertheless, SEC might still provide an indication on DNA
urity in downstream processing of the same virus strain.
. Conclusions
Pore diameter distribution of TSKgel 6000PWxl ranges from
0 nm to 2000 nm.  Intra-particle volume merges with the inter-
article volume. Separation of inﬂuenza A virus particle monomers,
ggregates and fragments is based on both, intra- and inter-particle
olume. Retention of whole virus particles from the H1N1 vaccine
train and the two strains propagated in embryonated chicken eggs
s similar. 100 mM sodium phosphate, pH 7.0 with 200 mM sodium
hloride seems to have appropriate ionic strength to prevent from
econdary interactions of the whole virus particles. This eluent pro-
ides full recovery of HA activity. More than 30% of the HA activity
f the samples is attributed to low molecular weight variants. These
irus particle fragments may  increase total HA activity, potentially
eading to overestimated hemagglutinin masses. Further, retention
f the whole virus particle peak can be used for estimating the
mount of surface adsorbed DNA.
Hence, SEC adds valuable data regarding the size distribution
f inﬂuenza virus samples to the commonly used HA assay for the
uantiﬁcation of inﬂuenza viruses. Alternatively, the method could
e combined with SRID. Future puriﬁcation processes may  beneﬁt
rom a more detailed picture of the virus size distribution and how
t is affected during the different steps of downstream processing. 1465 (2016) 117–125
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